Win Fight Against Cancer
At Boehringer Ingelheim we are giving patients new hope. We are collaborating with the oncology community on a shared journey to deliver leading science.
Search
Collaboration in Oncology
Oncology is a fast-moving, challenging and complex field and only with collaboration between different disciplines, we can be able to win the fight against cancer.
Leading Science in Oncology
As the oncology community learns more about the complexity of tumor biology, we are discovering new and exciting therapeutic opportunities.
NeO - smart and sustainable vaccines
The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.
Meet BIs Brains Michael Sand
Dr. Michael Sand, Senior Clinical Program Leader, CNS at Boehringer Ingelheim shares his view on the complexities of the CNS research landscape.
A Unique Bond: a brotherhood like no other
After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness.
A Unique Bond: friends in need
After suffering from a stroke, Phil’s connection with Valle helped change his life
A Unique Bond: by my side
Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life.
A Unique Bond: human and animal health
At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets.
We’re All In
Watch our video to learn about our approach to innovation and partnerships
Telling my story AF and DVT PE Patient Voices
Telling my story AF and DVT PE Patient Voices
Practical Advice
Practical advice for people with type 2 diabetes (T2D) at risk of heart disease
What are lay summaries
Boehringer Ingelheim produces lay summaries of clinical trials, making complex information and data from clinical studies understandable for patients and carers.
Nagoya Protocol
At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do.
Patient documentary - From diagnosis to everyday living
Patient documentary - From diagnosis to everyday living
Enterisol® Ileitis
For active immunisation of pigs from the age of three weeks against intestinal lesions caused by Lawsonia intracellularis infection and to reduce growth variability and weight loss associated with the disease.
Eprinex®
Depending on formulation, the product is for the treatment of nematodes, lice, mites, ticks, flies and lungworms in cattle and sheep.
Zactran®
Depending on species indication (and country of registration), the product is for the treatment and metaphylaxis control of respiratory disease in cattle caused by key bacteria (Mannheimia, Pasteurella, Histophilus and Mycoplasma) and footrot disease
Bovela®
Reduces hyperthermia and minimises the reduction of leukocyte count caused by BVD virus (BVDV-1, BVDV-2); reduces virus shedding and viraemia caused by BVDV-2 and prevents the birth of persistently infected calves caused by transplacental infection.
Pyramid® / Presponse®
The pyramid®/presponse® family of vaccines provides broad coverage for BVD types 1 and 2, IBR, BRSV, PI3 and Mannheimia haemolytica with only a single dose.
Metacam®
For the treatment of mastitis in lactating cows and for the control of pain associated with dehorning or surgery.
Gallimune® / Gallivac® / Volvac®
For vaccination of healthy chickens against diseases caused by the included antigens.
Prevexxion™ RN
The vaccine is recommended for in ovo vaccination of 18 to 19-day-old embryonated chicken eggs to protect against the very virulent Marek’s disease.
Newxxitek™ HVT+ND
The vaccination of 18 to 19-day-old embryos and one-day-old chickens is effective against Marek’s disease and Newcastle disease.
Aftopor®/Aftovaxpur®/Aftovax®/Aftobov®Oleosa/Aftovaxpur®Doe
FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®, Aftobov® Oleosa) allow differentiation between infected and vaccinated animals for endemic or emergency situations.